{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:36:01Z","timestamp":1775856961108,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Renal dysfunction results in the accumulation of various uremic toxins, including indoxyl sulphate (IS), and is a major risk factor for atrial fibrillation (AF). Experimental studies have demonstrated that IS exacerbates atrial remodelling via oxidative stress, inflammation, and fibrosis. However, its clinical impact on AF-promoting cardiac remodelling has not been described. Therefore, the purpose of this study was to clarify the relationship between basal IS levels and the 1-year outcomes after catheter ablation for the treatment of AF. Our prospective observational study included data from 125 patients with AF who underwent catheter ablation. Over a 1-year follow-up period, AF recurrence was identified in 21 patients. The 1-year AF-free survival was significantly lower in patients with high serum IS levels (\u22650.65\u2009\u03bcg\/mL) than in those with low IS levels (60.1\u2009\u00b1\u200910.4% <jats:italic>versus<\/jats:italic> 85.2\u2009\u00b1\u20093.9%, <jats:italic>P<\/jats:italic>\u2009=\u20090.007). Univariable analysis identified that an IS concentration\u2009\u2265\u20090.65\u2009\u03bcg\/mL was associated with AF recurrence (hazard ratio [HR]\u2009=\u20093.10 [1.26\u20137.32], <jats:italic>P<\/jats:italic>\u2009=\u20090.015), and this association was maintained in multivariate analysis (HR\u2009=\u20093.67 [1.13\u201311.7], <jats:italic>P<\/jats:italic>\u2009=\u20090.031). Thus, in patients undergoing AF ablation, serum IS levels at baseline independently predict the recurrence of arrhythmia.<\/jats:p>","DOI":"10.1038\/s41598-018-35226-5","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T15:17:15Z","timestamp":1542381435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Indoxyl Sulphate is Associated with Atrial Fibrillation Recurrence after Catheter Ablation"],"prefix":"10.1038","volume":"8","author":[{"given":"Fumi","family":"Yamagami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9759-1008","authenticated-orcid":false,"given":"Kazuko","family":"Tajiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Doki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2405-202X","authenticated-orcid":false,"given":"Junya","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Aita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Harunari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiro","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Murakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Aonuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ieda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"key":"35226_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ahj.2009.06.031","volume":"158","author":"H Watanabe","year":"2009","unstructured":"Watanabe, H. et al. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am. Heart J. 158, 629\u2013636 (2009).","journal-title":"Am. Heart J."},{"key":"35226_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1105594","volume":"367","author":"JB Olesen","year":"2012","unstructured":"Olesen, J. B. et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N. Engl. J. Med. 367, 625\u2013635 (2012).","journal-title":"N. Engl. J. Med."},{"key":"35226_CR3","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","volume":"123","author":"A Alonso","year":"2011","unstructured":"Alonso, A. et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 123, 2946\u20132953 (2011).","journal-title":"Circulation"},{"key":"35226_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.112.123992","volume":"127","author":"N Bansal","year":"2013","unstructured":"Bansal, N. et al. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 127, 569\u2013574 (2013).","journal-title":"Circulation"},{"key":"35226_CR5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.jacc.2016.06.057","volume":"68","author":"YC Lau","year":"2016","unstructured":"Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D. & Lip, G. Y. H. Atrial fibrillation and thromboembolism in patients with chronic kidney disease. J. Am. Coll. Cardiol. 68, 1452\u20131464 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"35226_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.hrthm.2010.10.047","volume":"8","author":"Y Naruse","year":"2011","unstructured":"Naruse, Y. et al. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up. Heart Rhythm 8, 335\u2013341 (2011).","journal-title":"Heart Rhythm"},{"key":"35226_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/hrt.2010.200824","volume":"97","author":"M Tokuda","year":"2011","unstructured":"Tokuda, M. et al. Relationship between renal function and the risk of recurrent atrial fibrillation following catheter ablation. Heart 97, 137\u2013142 (2011).","journal-title":"Heart"},{"key":"35226_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jjcc.2016.07.008","volume":"69","author":"S Yanagisawa","year":"2017","unstructured":"Yanagisawa, S. et al. Impaired renal function is associated with recurrence after cryoballoon catheter ablation for paroxysmal atrial fibrillation: A potential effect of non-pulmonary vein foci. J. Cardiol. 69, 3\u201310 (2017).","journal-title":"J. Cardiol."},{"key":"35226_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3390\/toxins6020665","volume":"6","author":"S Ito","year":"2014","unstructured":"Ito, S. & Yoshida, M. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients. Toxins (Basel) 6, 665\u2013678 (2014).","journal-title":"Toxins (Basel)"},{"key":"35226_CR10","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.112.278457","volume":"111","author":"S Lekawanvijit","year":"2012","unstructured":"Lekawanvijit, S., Kompa, A. R., Wang, B. H., Kelly, D. J. & Krum, H. Cardiorenal syndrome: The emerging role of protein-bound uremic toxins. Circ. Res. 111, 1470\u20131483 (2012).","journal-title":"Circ. Res."},{"key":"35226_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2013121283","volume":"26","author":"L Dou","year":"2015","unstructured":"Dou, L. et al. The cardiovascular effect of the uremic solute indole-3 acetic acid. J. Am. Soc. Nephrol. 26, 876\u2013887 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"35226_CR12","first-page":"259","volume":"32","author":"S-Y Huang","year":"2016","unstructured":"Huang, S.-Y., Chen, Y.-A., Chen, S.-A., Chen, Y.-J. & Lin, Y.-K. Uremic toxins\u2014novel arrhythmogenic factor in chronic kidney disease-related atrial fibrillation. Acta Cardiol. Sin. 32, 259\u2013264 (2016).","journal-title":"Acta Cardiol. Sin."},{"key":"35226_CR13","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.lfs.2013.05.008","volume":"92","author":"M Yisireyili","year":"2013","unstructured":"Yisireyili, M. et al. Indoxyl sulphate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats. Life Sci. 92, 1180\u20131185 (2013).","journal-title":"Life Sci."},{"key":"35226_CR14","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","volume":"31","author":"S Lekawanvijit","year":"2010","unstructured":"Lekawanvijit, S. et al. Does indoxyl sulphate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur. Heart J. 31, 1771\u20131779 (2010).","journal-title":"Eur. Heart J."},{"key":"35226_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/jce.12554","volume":"26","author":"W-T CHEN","year":"2015","unstructured":"CHEN, W.-T. et al. The uremic toxin indoxyl sulphate increases pulmonary vein and atrial arrhythmogenesis. J. Cardiovasc. Electrophysiol. 26, 203\u2013210 (2015).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"35226_CR16","doi-asserted-by":"publisher","first-page":"e002023","DOI":"10.1161\/JAHA.115.002023","volume":"4","author":"K Aoki","year":"2015","unstructured":"Aoki, K. et al. Role of indoxyl sulphate as a predisposing factor for atrial fibrillation in renal dysfunction. J. Am. Heart Assoc. 4, e002023 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"35226_CR17","first-page":"e199","volume":"130","author":"CT January","year":"2014","unstructured":"January, C. T. et al. 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130, e199\u2013e267 (2014).","journal-title":"Circulation"},{"key":"35226_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/chromsci\/bms103","volume":"51","author":"Z\u2019abi,M Al","year":"2013","unstructured":"Al, Z. \u2019abi,M., Ali, B. & Al Toubi, M. HPLC-fluorescence method for measurement of the uremic toxin indoxyl sulphate in plasma. J. Chromatogr. Sci. 51, 40\u201343 (2013).","journal-title":"J. Chromatogr. Sci."},{"key":"35226_CR19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in japan. Am. J. Kidney Dis. 53, 982\u2013992 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"35226_CR20","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","volume":"4","author":"FC Barreto","year":"2009","unstructured":"Barreto, F. C. et al. Serum indoxyl sulphate is associated with vascular disease and mortality in chronic kidney disease patients. Clin. J. Am. Soc. Nephrol. 4, 1551\u20131558 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"35226_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.arcmed.2012.08.002","volume":"43","author":"C-J Lin","year":"2012","unstructured":"Lin, C.-J. et al. Indoxyl sulphate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease. Arch. Med. Res. 43, 451\u2013456 (2012).","journal-title":"Arch. Med. Res."},{"key":"35226_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1253\/circj.CJ-12-0715","volume":"77","author":"S Shimazu","year":"2013","unstructured":"Shimazu, S. et al. Association between indoxyl sulphate and cardiac dysfunction and prognosis in patients with dilated cardiomyopathy. Circ. J. 77, 390\u2013396 (2013).","journal-title":"Circ. J."},{"key":"35226_CR23","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.amjcard.2012.11.025","volume":"111","author":"B Sato","year":"2013","unstructured":"Sato, B. et al. Relation of plasma indoxyl sulphate levels and estimated glomerular filtration rate to left ventricular diastolic dysfunction. Am. J. Cardiol. 111, 712\u2013716 (2013).","journal-title":"Am. J. Cardiol."},{"key":"35226_CR24","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.2215\/CJN.09981110","volume":"6","author":"S Eloot","year":"2011","unstructured":"Eloot, S. et al. Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins. Clin. J. Am. Soc. Nephrol. 6, 1266\u20131273 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"35226_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00467-017-3802-5","volume":"33","author":"E Snauwaert","year":"2018","unstructured":"Snauwaert, E. et al. Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease. Pediatr. Nephrol. 33, 315\u2013323 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"35226_CR26","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/j.ajkd.2015.08.029","volume":"67","author":"RC Vanholder","year":"2016","unstructured":"Vanholder, R. C., Eloot, S. & Glorieux, G. L. R. L. Future avenues to decrease uremic toxin concentration. Am. J. Kidney Dis. 67, 664\u2013676 (2016).","journal-title":"Am. J. Kidney Dis."},{"key":"35226_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/ki.2011.416","volume":"81","author":"JB Wetmore","year":"2012","unstructured":"Wetmore, J. B. et al. The prevalence of and factors associated with chronic atrial fibrillation in Medicare\/Medicaid-eligible dialysis patients. Kidney Int. 81, 469\u2013476 (2012).","journal-title":"Kidney Int."},{"key":"35226_CR28","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ki.2011.223","volume":"80","author":"CA Herzog","year":"2011","unstructured":"Herzog, C. A. et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 80, 572\u2013586 (2011).","journal-title":"Kidney Int."},{"key":"35226_CR29","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/ki.2009.477","volume":"77","author":"V Wizemann","year":"2010","unstructured":"Wizemann, V. et al. Atrial fibrillation in hemodialysis patients: Clinical features and associations with anticoagulant therapy. Kidney Int. 77, 1098\u20131106 (2010).","journal-title":"Kidney Int."},{"key":"35226_CR30","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1053\/j.ajkd.2005.07.044","volume":"46","author":"S Genovesi","year":"2005","unstructured":"Genovesi, S. et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am. J. Kidney Dis. 46, 897\u2013902 (2005).","journal-title":"Am. J. Kidney Dis."},{"key":"35226_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000329118","volume":"34","author":"H Fujii","year":"2011","unstructured":"Fujii, H., Kim, J.-I., Yoshiya, K., Nishi, S. & Fukagawa, M. Clinical characteristics and cardiovascular outcomes of hemodialysis patients with atrial fibrillation: a prospective follow-up study. Am. J. Nephrol. 34, 126\u2013134 (2011).","journal-title":"Am. J. Nephrol."},{"key":"35226_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1681\/ASN.2010050459","volume":"22","author":"WC Winkelmayer","year":"2011","unstructured":"Winkelmayer, W. C., Patrick, A. R., Liu, J., Brookhart, M. A. & Setoguchi, S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J. Am. Soc. Nephrol. 22, 349\u2013357 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"35226_CR33","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"V Fuster","year":"2006","unstructured":"Fuster, V. et al. ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114, e257\u2013e354 (2006).","journal-title":"Circulation"},{"key":"35226_CR34","first-page":"S211","volume":"63","author":"T Miyazaki","year":"1997","unstructured":"Miyazaki, T. et al. Indoxyl sulphate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure. Kidney Int. Suppl. 63, S211\u2013S214 (1997).","journal-title":"Kidney Int. Suppl."},{"key":"35226_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCEP.113.000374","volume":"6","author":"P Neuzil","year":"2013","unstructured":"Neuzil, P. et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ. Arrhythm. Electrophysiol. 6, 327\u2013333 (2013).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"35226_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/jce.13465","volume":"29","author":"E \u00dccer","year":"2018","unstructured":"\u00dccer, E. et al. A RAndomized Trial to compare the acute reconnection after pulmonary vein ISolation with Laser-BalloON versus radiofrequency Ablation: RATISBONA trial. J. Cardiovasc. Electrophysiol. 29, 733\u2013739 (2018).","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"4","key":"35226_CR37","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1373\/clinchem.2016.260117","volume":"63","author":"Matthew B. Rivara","year":"2017","unstructured":"Rivara, M. B. et al. Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion. Clinical Chemistry 63(4), 915\u2013923 (2017).","journal-title":"Clinical Chemistry"},{"issue":"10","key":"35226_CR38","doi-asserted-by":"publisher","first-page":"e0140820","DOI":"10.1371\/journal.pone.0140820","volume":"10","author":"Ruben Poesen","year":"2015","unstructured":"Poesen, R. et al. The Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites. PLOS ONE 10(10), e0140820 (2015).","journal-title":"PLOS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35226-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35226-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35226-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:46:20Z","timestamp":1671623180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35226-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35226"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35226-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]},"assertion":[{"value":"12 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.N. received honoraria from St. Jude Medical and Japan Lifeline, and an endowment from Medtronic and DVX. K.T. and Y.S. received an endowment from St. Jude Medical. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17276"}}